Quarterly Transactions Made in Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN). The information is specifically focused on institutions that hold shares of REGENERON PHARMACEUTICALS, INC..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 4,466,507 | 7,314,967 | 11,781,474 | 3,476,734 | 1,689,696 | 5,166,430 | 6,615,044 | |
Q4 2021 | 4,568,252 | 2,139,488 | 6,707,740 | 4,855,520 | 732,404 | 5,587,924 | 1,119,816 | |
Q1 2022 | 7,297,967 | 429,241 | 7,727,208 | 5,660,340 | 1,183,063 | 6,843,403 | 883,805 | |
Q2 2022 | 6,177,318 | 1,402,576 | 7,579,894 | 4,315,463 | 678,474 | 4,993,937 | 2,585,957 | |
Q3 2022 | 2,764,486 | 1,611,143 | 4,375,629 | 3,421,027 | 8,880 | 3,429,907 | 945,722 | |
Q4 2022 | 5,342,723 | 3,216,539 | 8,559,262 | 9,201,374 | 3,411 | 9,204,785 | -645,523 | |
Q1 2023 | 6,836,964 | 6,939,495 | 13,776,459 | 7,381,909 | 3,579 | 7,385,488 | 6,390,971 | |
Q2 2023 | 3,354,756 | 493,385 | 3,848,141 | 10,022,784 | 882,560 | 10,905,344 | -7,057,203 | |
Q3 2023 | 3,000,315 | 1,844,668 | 4,844,983 | 3,999,880 | 907,749 | 4,907,629 | -62,646 | |
Q4 2023 | 5,421,953 | 3,469,120 | 8,891,073 | 4,936,762 | 14 | 4,936,776 | 3,954,297 | |
Q1 2024 | 5,145,569 | 2,768,448 | 7,914,017 | 3,154,506 | 1,434 | 3,155,940 | 4,758,077 | |
Q2 2024 | 3,549,447 | 1,541,453 | 5,090,900 | 2,119,916 | 6,705 | 2,126,621 | 2,964,279 | |
Q3 2024 | 4,414,013 | 617,578 | 5,031,591 | 4,788,841 | 0 | 4,788,841 | 242,750 |